Magnetic Technology Corrects Limb Length Discrepancies
|
By HospiMedica International staff writers Posted on 13 Aug 2014 |

Image: The Ellipse Precice 2 Trauma Nail System ERC (Photo courtesy of Ellipse Technologies).
An intramedullary nail system use magnetic interaction to treat lower limb length discrepancies, often the result of acute or chronic fractures.
The Ellipse Precice 2 Trauma Nail System is composed of a medullary nail that contains an enclosed rare earth magnet, a telescoping lead assembly and locking screws, an internal planetary gearing system, surgical instruments, and an external remote controller (ERC). The nail system, which is supplied pre-distracted to allow for compression fracture reduction techniques, is available in various diameters, lengths, and screw-hole configurations to accommodate a variety of patient anatomies; the locking screws are also available in a variety of diameters and lengths.
To perform bone distraction, the medullary nail is inserted into the intramedullary canal of the femur and/or the tibia and secured with the locking screws. The telescoping assembly can then be adjusted noninvasively via the Ellipse ERC. The controlled, customized distraction allows for a precision lengthening phase with the ability to shorten the device if necessary. Using the ERC, The implant can be lengthened in the clinic or by the patient at home, according to the physician's direction. The Ellipse Precice 2 Trauma Nail System is a product of Ellipse Technologies (Irvine, CA, USA).
“The introduction of the Precice 2 system complements the early success of the Precice device with improved efficiency in the operating room and the larger range of patients with limb length inequality who can now be treated,” said Ed Roschak, president and CEO of Ellipse. “We continue to work every day to apply our platform technology to address unmet needs in orthopedics and spine.”
Surgical distraction osteogenesis limb lengthening methods use various constructs, which can be divided into three main groups: external, internal (intraosseal), and combined (mixed) methods. All methods generally include bone dissection, gradual bone part separation at an average speed of 1 mm a day, and the regeneration of bone stretched to the new length, which is totally ossified only after distraction is terminated. A sparing environment for muscles and joints is necessary during stretching and regeneration.
Related Links:
Ellipse Technologies
The Ellipse Precice 2 Trauma Nail System is composed of a medullary nail that contains an enclosed rare earth magnet, a telescoping lead assembly and locking screws, an internal planetary gearing system, surgical instruments, and an external remote controller (ERC). The nail system, which is supplied pre-distracted to allow for compression fracture reduction techniques, is available in various diameters, lengths, and screw-hole configurations to accommodate a variety of patient anatomies; the locking screws are also available in a variety of diameters and lengths.
To perform bone distraction, the medullary nail is inserted into the intramedullary canal of the femur and/or the tibia and secured with the locking screws. The telescoping assembly can then be adjusted noninvasively via the Ellipse ERC. The controlled, customized distraction allows for a precision lengthening phase with the ability to shorten the device if necessary. Using the ERC, The implant can be lengthened in the clinic or by the patient at home, according to the physician's direction. The Ellipse Precice 2 Trauma Nail System is a product of Ellipse Technologies (Irvine, CA, USA).
“The introduction of the Precice 2 system complements the early success of the Precice device with improved efficiency in the operating room and the larger range of patients with limb length inequality who can now be treated,” said Ed Roschak, president and CEO of Ellipse. “We continue to work every day to apply our platform technology to address unmet needs in orthopedics and spine.”
Surgical distraction osteogenesis limb lengthening methods use various constructs, which can be divided into three main groups: external, internal (intraosseal), and combined (mixed) methods. All methods generally include bone dissection, gradual bone part separation at an average speed of 1 mm a day, and the regeneration of bone stretched to the new length, which is totally ossified only after distraction is terminated. A sparing environment for muscles and joints is necessary during stretching and regeneration.
Related Links:
Ellipse Technologies
Latest Surgical Techniques News
- Surgical Innovation Cuts Ovarian Cancer Risk by 80%
- New Imaging Combo Offers Hope for High-Risk Heart Patients
- New Classification System Brings Clarity to Brain Tumor Surgery Decisions
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
- NIR Light Enables Powering and Communicating with Implantable Medical Devices
- Simple Bypass Protocol Improves Outcomes in Chronic Cerebral Occlusion
- Implantable Absorbable Sensor Detects Life-Threatening Complications After Intestinal Surgery
Channels
Artificial Intelligence
view channelCritical Care
view channel
Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
Glioblastoma is the most common and aggressive form of brain tumor, characterized by rapid growth, high invasiveness, and an extremely poor prognosis. Even with surgery followed by radiotherapy and chemotherapy,... Read more
Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
Vancomycin is a powerful antibiotic used in hospitals to treat severe drug-resistant infections and life-threatening bloodstream infections. However, dosing the drug is notoriously difficult, as too little... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







